pharmacokinetics of glp 1 receptor agonists a long-acting GLP-1 agonist in minipigs Pharmacodynamic and pharmacokinetic profiles of

- **Slow digestion:** Delaying stomach emptying to prevent spikes in sugar levels after meals

Not approved for diagnostic, therapeutic, or medical applications

Results The first cohort included 36082 GLP-1 receptor agonist users (median follow-up 1.3 years) and 234028 DPP-4 inhibitor users (median follow-up 1.7 years)

This bundle features our High-Potency Multi, formulated to address common nutrient deficiencies, and our Dual-Action Probiotic, which combines a clinically-studied probiotic strain, prebiotic fibre, and ginger to promote digestive comfort

GLP-1 medications can provide major health benefits, but recent studies have raised questions about a possible link with NAION, a rare optic nerve condition that can cause sudden vision loss

GLP-1 agonists may lessen alcohol, smoking and possibly drug addictions